Company intelligence / Profile preview
CeNeRx BioPharma
Cary, North Carolina, United Statesbiospace.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
CeNeRx BioPharma was a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system disorders. Its lead program was Tyrima™/TriRima™, a selective and reversible inhibitor of monoamine oxidase A with a triple-action mechanism targeting serotonin, norepinephrine, and dopamine. This candidate advanced to Phase II trials for major depressive disorder. The pipeline also included selective cannabinoid compounds in preclinical development for pain-related conditions and an orally active nerve growth factor enhancer intended to treat neuropathies and neurodegenerative diseases. Initial results from the Tyrima Phase II trial were expected by late 2009.[6][7][8]
- Therapeutic areas
- OphthalmologyEndocrinologyPsychiatryNeurology
- Modalities
- Small molecules (e.g., reversible MAO-A inhibitors, cannabinoid compounds)Orally active agents (e.g., NGF enhancers)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on CeNeRx BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CeNeRx BioPharma.